J&J’s newly diagnosed multiple myeloma induction combo elicits 100% OR

Johnson & Johnson’s (J&J’s) multiple myeloma combination of Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and ...
Devdiscourse

Lupin Gains USFDA Approval for Cancer Drug Lenalidomide

Lupin has been granted approval by the USFDA to market Lenalidomide Capsules, a cancer treatment drug, in the US. The drug, a bioequivalent to Revlimid by Bristol-Myers Squibb, will be produced at ...
Cure Today

FDA Approves Adcetris With Revlimid and Rituxan For R/R LBCL

FDA approved Adcetris, Revlimid, and Rituxan for relapsed/refractory LBCL patients ineligible for auto-HSCT or CAR-T therapy, based on ECHELON-3 trial results. The combination therapy showed ...

Lupin gets U.S. FDA nod for generic of cancer drug Revlimid capsules

Lupin receives FDA approval for Lenalidomide Capsules, a generic version of Revlimid, for multiple myeloma treatment.
CNBCTV18

Lupin gets USFDA nod for drug to treat Multiple Myeloma

Lupin has bagged the approval for Lenalidomide capsules. This drug is used in the treatment of Multiple Myeloma (MM). In an ...
Cure Today

Monjuvi Combo Reduces Progression Risk in Follicular Lymphoma

Monjuvi, combined with Rituxan and Revlimid, extends progression-free survival to 22 months, reducing disease progression risk by over 50%. The inMIND trial's design and diverse patient population ...
Rediff Money

Lupin Gets USFDA Nod for Generic Cancer Drug

Lupin receives USFDA approval to market Lenalidomide Capsules, a generic cancer treatment drug, in the US. Boost for cancer ...